Xi'an-based Particle Cloud Biotechnology develops 3D-printed regenerative artificial bone and bioprinting technology.
Based in Xi'an, China and established in 2014, Xi'an Particle Cloud Biotechnology Co., Ltd. develops biomaterials such as regenerative artificial bone using 3D printing. In 2018 it completed the world's first clinical transplantation for regenerative repair of large bone defects. Its products include ceramic and biological 3D printers, and it offers customized bioprinting services. In October 2023 it raised a strategic investment from new investors Capitech Venture Capital and Tianhong Investment, and returning investor Zhengxin Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in